Cardiovascular risk in relation to α-adducin Gly460Trp polymorphism and systolic pressure: A prospective population study

Hypertension

Volumn 46, Issue 3, 2005, Pages 527-532

  Li, Yan ^a   Thijs, Lutgarde ^a   Kuznetsova, Tatiana ^a   Zagato, Laura ^b   Struijker Boudier, Harry ^c   Bianchi, Giuseppe ^b   Staessen, Jan A ^a,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Epidemiology; Genes; Morbidity

Indexed keywords

ADDUCIN; ALPHA ADDUCIN; GLYCINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOMOZYGOSITY; HUMAN; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CALMODULIN-BINDING PROTEINS; CARDIOVASCULAR DISEASES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCINE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RISK; TRYPTOPHAN;

EID: 25444438244     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000174988.81829.72     Document Type: Article

References (26)

1. Matsuoka Y, Li X, Bennett V. Adducin: structure, function and regulation. Cell Mol Life Sci. 2000;57:884-895.
2. Bianchi G, Tripodi MG, Casari G, Salardi S, Barber BR, Garcia R, Leoni P, Torielli L, Cusi D, Ferrandi M, Pinna LA, Baralle FE, Ferrari P. Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci USA. 1994;91:3999-4003.
3. +-ATPase: relation to genetic hypertension. Am J Physiol. 1999;277:H1338-H1349.
4. Tripodi MG, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, Menegon A, Ferrari P, Marchisio PC, Bianchi G. Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest. 1996;97:2815-2822.
5. Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D. ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension. 2003;41:398-403.
6. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet. 1997;349:1353-1357.
7. Wang JG, Staessen JA, Barlassina C, Fagard R, Kuznetsova T, Stuijker-Boudier HA, Zagato L, Citterio L, Messaggio E, Bianchi G. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population. Kidney Int. 2002;62:2152-2159.
8. Province MA, Arnett DK, Hunt SC, Leiendecker-Foster C, Eckfeldt JH, Oberman A, Ellison RC, Heiss G, Mockrin SC, Williams RR. Association between the alpha-adducin gene and hypertension in the HyperGEN Study. Am J Hypertens. 2000;13:710-718.
9. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G. Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens. 2001;19:1349-1358.
10. Grant FD, Romero JR, Jeunemaitre X, Hunt SC, Hopkins PN, Hollenberg NH, Williams GH. Low-renin hypertension, altered sodium homeostasis, and an alpha-adducin polymorphism. Hypertension. 2002;39:191-196.
11. Glorioso N, Filigheddu F, Cusi D, Troffa C, Conti M, Natalizio M, Argiolas G, Barlassina C, Bianchi G. Alpha-adducin 460Trp allele is associated with erythrocyte Na transport in North Sardinian primary hypertensives. Hypertension. 2002;39:357-362.
12. Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, Wang J, Li Y, Bianchi G, Staessen JA, Liu L. Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens. 2004;22:937-944.
13. Balkestein EJ, Wang JG, Struijker-Boudier HA, Barlassina C, Bianchi G, Birkenhager WH, Brand E, Den Hond E, Fagard R, Herrmann SM, Van Bortel LM, Staessen JA. Carotid and femoral intima-media thickness in relation to three candidate genes in a Caucasian population. J Hypertens. 2002;20:1551-1561.
14. Wang JG, Staessen JA, Tizzoni L, Brand E, Birkenhager WH, Fagard R, Herrmann SM, Bianchi G. Renal function in relation to three candidate genes. Am J Kidney Dis. 2001;38:1158-1168.
15. Beeks E, van der Klauw MM, Kroon AA, Spiering W, Fuss-Lejeune MJMJ, de Leeuw PW. Alpha-adducin Gly460Trp polymorphism and renal hemodynamics in essential hypertension. Hypertension. 2004;44: 419-423.
16. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J. 2004;25:459-467.
17. Persu A, El-Khattabi O, Messiaen T, Pirson Y, Chauveau D, Devuyst O. Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2003;18:2032-2038.
18. Psaty BM, Smith NL, Heckbert SR, Vos HL, Lemaitre RN, Reiner AP, Siscovick DS, Bis J, Lumley T, Longstreth WT Jr, Rosendaal FR. Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. J Am Med Assoc. 2002;287:1680-1689.
19. Morrison AC, Bray MS, Folsom AR, Boerwinkle E. ADD1 460W allele associated with cardiovascular disease in hypertensive individuals. Hypertension. 2002;39:1053-1057.
20. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report. J Am Med Assoc. 2003;289:2560-2572.
21. Holtzman NA, Marteau TM. Will genetics revolutionize medicine? N Engl J Med. 2000;343:141-144.
22. Bianchi G, Ferrari P, Staessen JA. Adducin polymorphism detection and impact on Hypertension. Hypertension. 2005;45:331-340.
23. Manunta P, Cusi D, Barlassina C, Righetti M, Lanzani C, D'Amico M, Buzzi L, Citterio L, Stella P, Rivera R, Bianchi G. Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int. 1998;53:1471-1478.
24. Manunta P, Burnier M, D'Amico M, Buzzi L, Maillard M, Barlassina C. Lanella G, Cusi D, Bianchi G. Adducin polymorphism affects renal proximal tubule reabsorption in hypertension. Hypertension. 1999;33: 694-697.
25. Staessen JA, Wang J, Bianchi G, Birkenhäger WH. Essential hypertension. Lancet. 2003;361:1629-1641.
26. Tikhonoff V, Kuznetsova T, Stolarz K, Bianchi G, Casiglia E, Kawecka-Jaszcz K, Nikitin Y, Tizzone L, Wang JG, Staessen JA; European Project on Genes in Hypertension (EPOGH) Investigators. Beta-adducin polymorphisms, blood pressure and sodium excretion in three European populations. Am J Hypertens. 2003;16:840-846.